Cargando…
Duration of frontline therapy and impact on clinical outcomes in newly diagnosed multiple myeloma patients not receiving frontline stem cell transplant
BACKGROUND: Extended first‐line therapy (1LT) has improved clinical outcomes in newly diagnosed multiple myeloma (NDMM). This retrospective study of NDMM patients evaluated the relationship between dose‐attenuation of 1LT and duration of therapy (DOT) and DOT on outcomes. METHODS: Adults with NDMM n...
Autores principales: | Ailawadhi, Sikander, Ogbonnaya, Augustina, Murty, Sharanya, Cherepanov, Dasha, Schroader, Bridgette Kanz, Romanus, Dorothy, Farrelly, Eileen, Chari, Ajai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939178/ https://www.ncbi.nlm.nih.gov/pubmed/36151787 http://dx.doi.org/10.1002/cam4.5239 |
Ejemplares similares
-
Economic Impact of Transformation to Acute Myeloid Leukemia Among Actively Managed Patients with Higher-Risk Myelodysplastic Syndromes in the United States
por: Kota, Vamsi, et al.
Publicado: (2022) -
Frontline therapy for newly diagnosed patients with multiple myeloma
por: Jung, Sung-Hoon, et al.
Publicado: (2020) -
Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma
por: Fonseca, Rafael, et al.
Publicado: (2020) -
Angola in the frontline /
por: Wolfers, Michael, 1938-2014
Publicado: (1983) -
Leading on the Frontline
por: Cruse, Linda
Publicado: (2018)